Understanding reasons for non-adherence to active surveillance for low-intermediate risk prostate cancer

BACKGROUND: Active surveillance (AS) is recommended by most national medical organizations as the preferred treatment option for men with low-risk prostate cancer (PCa). However, studies report that up to one third of men on AS dropout within 5 years, without evidence of disease progression. Despite...

Descripción completa

Detalles Bibliográficos
Autores principales: Beckmann, Kerri, Cahill, Declan, Brown, Christian, Van Hemelrijck, Mieke, Kinsella, Netty
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article on Expectant Management in Genitourinary Malignancies (Prostate, Bladder, Kidney)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261438/
https://www.ncbi.nlm.nih.gov/pubmed/34295758
http://dx.doi.org/10.21037/tau-20-1254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261438/
https://www.ncbi.nlm.nih.gov/pubmed/34295758
http://dx.doi.org/10.21037/tau-20-1254

Ejemplares similares